Cargando…

Drug induced oral erythema multiforme: Case report

INTRODUCTION: Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations. PATIENT CONCERNS: This article presents...

Descripción completa

Detalles Bibliográficos
Autores principales: Asif, Shaik Mohamed, Shamsudeen, Shaik Mohamed, Assiri, Khalil Ibrahim, Muburak, Hussain Mohammed Al, Kaleem, Sultan Mohammed, Khan, Abdul Ahad, Shariff, Mansoor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084015/
https://www.ncbi.nlm.nih.gov/pubmed/33907086
http://dx.doi.org/10.1097/MD.0000000000022387
_version_ 1783686065171726336
author Asif, Shaik Mohamed
Shamsudeen, Shaik Mohamed
Assiri, Khalil Ibrahim
Muburak, Hussain Mohammed Al
Kaleem, Sultan Mohammed
Khan, Abdul Ahad
Shariff, Mansoor
author_facet Asif, Shaik Mohamed
Shamsudeen, Shaik Mohamed
Assiri, Khalil Ibrahim
Muburak, Hussain Mohammed Al
Kaleem, Sultan Mohammed
Khan, Abdul Ahad
Shariff, Mansoor
author_sort Asif, Shaik Mohamed
collection PubMed
description INTRODUCTION: Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations. PATIENT CONCERNS: This article presents 2 case reports of Oral erythema multiforme in which drugs were the precipitating factor. Its etiopathogenesis, differential diagnosis and treatment modalities of the disease is discussed. DIAGNOSIS: Based on patient's complaints, drug history and clinical appearance, provisional diagnosis of drug induced erythema multiforme was considered. INTERVENTION: For case 1, patient was instructed to discontinue usage of drug and prescribed systemic steroid (Prednisolone 10 mg/d) for a week along with germicidal drugs to prevent secondary infection. Medication was tapered to 5 mg/d after first week. For case 2, patient was instructed to discontinue the drug and systemic steroid prednisolone 20 mg /d for 1 week with tapering dose of 10 mg/d for the second week was administered. OUTCOME: For case 1 and case 2 healing of the lesions were evident on third week of follow up. CONCLUSION: Medications should be taken under medical supervision. Over the counter drugs might lead to allergic reactions like drug induced oral erythema multiforme, which is a rare variant and needs to be differentiate from other oral ulcerative lesion for prompt management and follow-up.
format Online
Article
Text
id pubmed-8084015
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-80840152021-05-01 Drug induced oral erythema multiforme: Case report Asif, Shaik Mohamed Shamsudeen, Shaik Mohamed Assiri, Khalil Ibrahim Muburak, Hussain Mohammed Al Kaleem, Sultan Mohammed Khan, Abdul Ahad Shariff, Mansoor Medicine (Baltimore) 5900 INTRODUCTION: Drug induced oral erythema multiforme a rare clinical entity which involves only the lips and oral mucosa without skin involvement. These lesions are difficult in diagnosing with other oral ulcerative lesions with similar clinical manifestations. PATIENT CONCERNS: This article presents 2 case reports of Oral erythema multiforme in which drugs were the precipitating factor. Its etiopathogenesis, differential diagnosis and treatment modalities of the disease is discussed. DIAGNOSIS: Based on patient's complaints, drug history and clinical appearance, provisional diagnosis of drug induced erythema multiforme was considered. INTERVENTION: For case 1, patient was instructed to discontinue usage of drug and prescribed systemic steroid (Prednisolone 10 mg/d) for a week along with germicidal drugs to prevent secondary infection. Medication was tapered to 5 mg/d after first week. For case 2, patient was instructed to discontinue the drug and systemic steroid prednisolone 20 mg /d for 1 week with tapering dose of 10 mg/d for the second week was administered. OUTCOME: For case 1 and case 2 healing of the lesions were evident on third week of follow up. CONCLUSION: Medications should be taken under medical supervision. Over the counter drugs might lead to allergic reactions like drug induced oral erythema multiforme, which is a rare variant and needs to be differentiate from other oral ulcerative lesion for prompt management and follow-up. Lippincott Williams & Wilkins 2021-04-30 /pmc/articles/PMC8084015/ /pubmed/33907086 http://dx.doi.org/10.1097/MD.0000000000022387 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 (https://creativecommons.org/licenses/by/4.0/)
spellingShingle 5900
Asif, Shaik Mohamed
Shamsudeen, Shaik Mohamed
Assiri, Khalil Ibrahim
Muburak, Hussain Mohammed Al
Kaleem, Sultan Mohammed
Khan, Abdul Ahad
Shariff, Mansoor
Drug induced oral erythema multiforme: Case report
title Drug induced oral erythema multiforme: Case report
title_full Drug induced oral erythema multiforme: Case report
title_fullStr Drug induced oral erythema multiforme: Case report
title_full_unstemmed Drug induced oral erythema multiforme: Case report
title_short Drug induced oral erythema multiforme: Case report
title_sort drug induced oral erythema multiforme: case report
topic 5900
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8084015/
https://www.ncbi.nlm.nih.gov/pubmed/33907086
http://dx.doi.org/10.1097/MD.0000000000022387
work_keys_str_mv AT asifshaikmohamed druginducedoralerythemamultiformecasereport
AT shamsudeenshaikmohamed druginducedoralerythemamultiformecasereport
AT assirikhalilibrahim druginducedoralerythemamultiformecasereport
AT muburakhussainmohammedal druginducedoralerythemamultiformecasereport
AT kaleemsultanmohammed druginducedoralerythemamultiformecasereport
AT khanabdulahad druginducedoralerythemamultiformecasereport
AT shariffmansoor druginducedoralerythemamultiformecasereport